Juan J. Canales, D.Phil.

Affiliations: 
University of Canterbury, New Zealand, Christchurch, Canterbury, New Zealand 
Google:
"Juan Canales"
Mean distance: 13.3 (cluster 19)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Schwartz MD, Canales JJ, Zucchi R, et al. (2018) Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases. Expert Opinion On Therapeutic Targets
Pei Y, Asif-Malik A, Canales JJ. (2016) Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications. Frontiers in Neuroscience. 10: 148
Pei Y, Mortas P, Hoener MC, et al. (2015) Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 63: 70-5
Hamilton J, Lee J, Canales JJ. (2015) Chronic unilateral stimulation of the nucleus accumbens at high or low frequencies attenuates relapse to cocaine seeking in an animal model. Brain Stimulation. 8: 57-63
Pei Y, Lee J, Leo D, et al. (2014) Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seeking. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2299-308
Ferragud A, Velázquez-Sánchez C, Canales JJ. (2014) Modulation of methamphetamine's locomotor stimulation and self-administration by JHW 007, an atypical dopamine reuptake blocker. European Journal of Pharmacology. 731: 73-9
Velázquez-Sánchez C, García-Verdugo JM, Murga J, et al. (2013) The atypical dopamine transport inhibitor, JHW 007, prevents amphetamine-induced sensitization and synaptic reorganization within the nucleus accumbens. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 44: 73-80
Velázquez-Sánchez C, Ferragud A, Ramos-Miguel A, et al. (2013) Substituting a long-acting dopamine uptake inhibitor for cocaine prevents relapse to cocaine seeking. Addiction Biology. 18: 633-43
Revel FG, Moreau JL, Gainetdinov RR, et al. (2012) Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biological Psychiatry. 72: 934-42
Velázquez-Sánchez C, Canales JJ. (2012) Atypical dopamine transporter inhibitors: Candidates for the treatment of psychostimulant addiction Emerging Targets For Drug Addiction Treatment. 133-150
See more...